Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibo Liu

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Cancer Letters|January 2, 2017
Whole-genome sequencing reveals the mutational landscape of metastatic small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC)Maolan Li, Fatao Liu, Yijian Zhang, et al.
Cancer Letters|January 23, 2016
LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathwayZhiZhen Li, YuanYuan Chen, XuAn Wang, et al.
Cancer Letters|March 8, 2016
A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growthYijian Zhang, Shibo Liu, Lei Wang, et al.
Cancer Letters|April 30, 2016
Corrigendum to <LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway> <Cancer Lett. 372 (2016) 239-250>ZhiZhen Li, YuanYuan Chen, XuAn Wang, et al.
Cancer Letters|March 26, 2025
Corrigendum to "LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway" [Cancer Lett. 372 (2016) 239-250]ZhiZhen Li, YuanYuan Chen, XuAn Wang, et al.
Science (New York, N.Y.)|June 4, 2026
Ultralow chromium doping enables all-PbSe thermoelectric coolingShibo Liu, Yu Tian, Yi Wen, et al.
Cell|November 6, 2024
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Cell|June 25, 2026
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Science Advances|September 10, 2025
Magnetic field-enhanced vertical integration enables embodied intelligence in untethered soft robotsXiaosa Li, Xiao Xiao, Xiao Xiao, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Cancer Letters|January 2, 2017
Whole-genome sequencing reveals the mutational landscape of metastatic small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC)Maolan Li, Fatao Liu, Yijian Zhang, et al.
Cancer Letters|January 23, 2016
LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathwayZhiZhen Li, YuanYuan Chen, XuAn Wang, et al.
Cancer Letters|March 8, 2016
A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growthYijian Zhang, Shibo Liu, Lei Wang, et al.
Cancer Letters|April 30, 2016
Corrigendum to <LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway> <Cancer Lett. 372 (2016) 239-250>ZhiZhen Li, YuanYuan Chen, XuAn Wang, et al.
Cancer Letters|March 26, 2025
Corrigendum to "LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway" [Cancer Lett. 372 (2016) 239-250]ZhiZhen Li, YuanYuan Chen, XuAn Wang, et al.
Science (New York, N.Y.)|June 4, 2026
Ultralow chromium doping enables all-PbSe thermoelectric coolingShibo Liu, Yu Tian, Yi Wen, et al.
Cell|November 6, 2024
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Cell|June 25, 2026
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Science Advances|September 10, 2025
Magnetic field-enhanced vertical integration enables embodied intelligence in untethered soft robotsXiaosa Li, Xiao Xiao, Xiao Xiao, et al.
Pageof 13